Akso Health director files initial Form 3

Akso Health Group director Wang Yilin has filed an initial statement of beneficial ownership on Form 3.

Accepted by SEC EDGAR 03/18/2026 - 10:16 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Akso Health Group director Wang Yilin has filed an initial statement of beneficial ownership on Form 3. This filing establishes Wang Yilin’s reporting status as a director of Akso Health Group but does not list any reportable transactions or holdings in this excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Akso Health Group (AHG) Form 3 filing by Wang Yilin show?

The Form 3 filing shows that Wang Yilin is a director of Akso Health Group. It serves as an initial statement of beneficial ownership and, in this excerpt, does not include any reportable transactions or holdings.

Did Wang Yilin report any stock transactions in the Akso Health Group (AHG) Form 3?

No transactions are reported for Wang Yilin in this Form 3 excerpt. The transaction summary shows zero buys, sells, exercises, gifts, or other dispositions, indicating no reportable trading activity in this data.

What insider activity counts are shown in the Akso Health Group (AHG) Form 3 summary?

The transaction summary shows zero buy, sell, exercise, gift, tax withholding, and restructuring events. It also reports netBuySellDirection as neutral and no derivative transactions for this reporting person in the excerpt.

What role does Wang Yilin hold at Akso Health Group (AHG) according to the Form 3?

According to the Form 3 data, Wang Yilin is a director of Akso Health Group. The filing flags them as a director, with no officer role or ten percent owner status indicated in the provided information.

Does the Akso Health Group (AHG) Form 3 include any derivative positions for Wang Yilin?

The derivative section in this Form 3 excerpt is empty, and derivativeTransactionCount is zero. This means no options, warrants, or other derivative securities are reported for Wang Yilin in the provided data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Yilin

(Last) (First) (Middle)

ROOM 8201-4-4(A), 2ND FLOOR, QIANTONGYUA

QIANWAN BONDED PORT AREA

(Street)

QINGDAO SHANDONG 266000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Akso Health Group [ AHG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	Yilin Wang	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)